866
Views
3
CrossRef citations to date
0
Altmetric
Original Research

mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model

, , , , &
Article: e1160183 | Received 14 Oct 2015, Accepted 25 Feb 2016, Published online: 28 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mareike Grees, Adi Sharbi-Yunger, Christos Evangelou, Daniel Baumann, Gal Cafri, Esther Tzehoval, Stefan B. Eichmüller, Rienk Offringa, Jochen Utikal, Lea Eisenbach & Viktor Umansky. (2018) Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models. OncoImmunology 7:7.
Read now

Articles from other publishers (2)

Adam Solomon, Zoya Alteber, David Bassan, Adi Sharbi‐Yunger, Simon Esbit, Esther Tzehoval & Lea Eisenbach. (2022) On the development of a neoantigen vaccine for the prevention of Lynch Syndrome. International Journal of Cancer 151:1, pages 107-119.
Crossref
Adi Sharbi-Yunger, Mareike Grees, Gal Cafri, David Bassan, Stefan B. Eichmüller, Esther Tzehoval, Jochen Utikal, Viktor Umansky & Lea Eisenbach. (2019) A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival. International Journal of Cancer 144:4, pages 909-921.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.